Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Board/Management Information 2015

Apr 24, 2015

30403_rns_2015-04-24_e4d93e84-bdcd-4492-bed8-d39ab27519eb.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 clorox_8k.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______

FORM 8-K

CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2015

THE CLOROX COMPANY (Exact name of registrant as specified in its charter)

_______

Delaware 1-07151 31-0595760
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)

1221 Broadway, Oakland, California 94612-1888 (Address of principal executive offices) (Zip code)

(510) 271-7000 (Registrant's telephone number, including area code)

Not applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| [ ] | Written communications
pursuant to Rule 425 Under the Securities Act (17 CFR 230.425) |
| --- | --- |
| [ ] | Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| [ ] | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On April 21, 2015, Daniel Boggan, Jr., notified the board of directors (the “Board”) of The Clorox Company (the “Company”) that he is retiring from the Board effective May 13, 2015. Mr. Boggan has served as a director of the Company since 1990. Mr. Boggan’s decision to retire is not as a result of any disagreement with the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| THE CLOROX
COMPANY — /s/ Laura Stein |
| --- |
| Executive Vice
President – General Counsel |